Pages
-
I-TECH Receives Five-Year Cooperative Agreement to Train and Mentor Zimbabwe Medical Staff
A $42.9 million award from the Centers for Disease Control and Prevention (CDC) will enable I-TECH to support Zimbabwe’s Ministry of Health and Child Care (MOHCC) in training healthcare workers throughout the country in an integrated approach to care...
-
New UW SPH leaders appointed for 2024-2025 academic year
New-SPH-leadership-2024-1200x650.jpg ...
-
UW Center for AIDS Research: Humoral Immunology Subcore
The Humoral Immunity Core serves the needs of the CFAR community for Immune-based assays and provides training and assays on a fee-for-service basis to investigators who are CFAR affiliated at the University of Washington and elsewhere. Services offered...
-
Scientists Denounce Trump Administration’s Climate Report
News-default.jpg ...
-
Pakistan bears the brunt of global extreme heat illness and mortality
Pakistan is the epicenter of a new global wave of disease and death linked to climate change, according to a Washington Post analysis of climate data, leading scientific studies, interviews with experts and reporting from some of the places bearing the...
-
Prof. Dean Jamison Profiled in The Lancet
Dean Jamison.jpg ...
-
Jodi Greathouse
Grants Manager, CORE Hans Rosling Center 3980 15th Ave. Box 351620 Seattle, WA 98195 United States Email: jodiv@uw.edu
-
NewsBeat: Service-Minded Student Wins National Family Medicine Honor
By Brian Donohue ...
-
Kenya Tuberculosis Research & Training Program-UW (KTRTP UW)
This program supports the creation of UW Kenya TB Research and Training Program (KTRTP) to catalyze research, training, and collaboration between Seattle and Kenya investigators as well as the development of infrastructure and a collaborative framework...
-
Development of a pre-erythrocytic P. vivax vaccine to prevent clinical relapse
The goal of this project is the development of a vaccine targeting the pre-erythrocytic stages of malaria infection to prevent relapse infection by Plasmodium vivax. Because 80-90% of active blood stage P. vivax infections come from relapse, and not...